1. Home
  2. ADVM vs HMR Comparison

ADVM vs HMR Comparison

Compare ADVM & HMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • HMR
  • Stock Information
  • Founded
  • ADVM 2006
  • HMR 1984
  • Country
  • ADVM United States
  • HMR Greece
  • Employees
  • ADVM N/A
  • HMR N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • HMR Marine Transportation
  • Sector
  • ADVM Health Care
  • HMR Consumer Discretionary
  • Exchange
  • ADVM Nasdaq
  • HMR Nasdaq
  • Market Cap
  • ADVM 94.6M
  • HMR 77.4M
  • IPO Year
  • ADVM 2014
  • HMR N/A
  • Fundamental
  • Price
  • ADVM $4.48
  • HMR N/A
  • Analyst Decision
  • ADVM Strong Buy
  • HMR Strong Buy
  • Analyst Count
  • ADVM 4
  • HMR 2
  • Target Price
  • ADVM $19.75
  • HMR $6.00
  • AVG Volume (30 Days)
  • ADVM 800.9K
  • HMR 99.2K
  • Earning Date
  • ADVM 11-03-2025
  • HMR 11-11-2025
  • Dividend Yield
  • ADVM N/A
  • HMR N/A
  • EPS Growth
  • ADVM N/A
  • HMR N/A
  • EPS
  • ADVM N/A
  • HMR N/A
  • Revenue
  • ADVM $1,000,000.00
  • HMR $27,657,887.00
  • Revenue This Year
  • ADVM $1,449.40
  • HMR $36.04
  • Revenue Next Year
  • ADVM N/A
  • HMR $35.83
  • P/E Ratio
  • ADVM N/A
  • HMR N/A
  • Revenue Growth
  • ADVM N/A
  • HMR N/A
  • 52 Week Low
  • ADVM $1.78
  • HMR $1.09
  • 52 Week High
  • ADVM $8.56
  • HMR $10.04
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 53.05
  • HMR N/A
  • Support Level
  • ADVM $4.11
  • HMR N/A
  • Resistance Level
  • ADVM $5.59
  • HMR N/A
  • Average True Range (ATR)
  • ADVM 0.52
  • HMR 0.00
  • MACD
  • ADVM -0.09
  • HMR 0.00
  • Stochastic Oscillator
  • ADVM 27.75
  • HMR 0.00

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About HMR Heidmar Maritime Holdings Corp. Common Stock

Heidmar Maritime Holdings Corp is an asset-light tanker pool, and commercial and technical management company. The company is a fast-growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. The company has also recently expanded its business to offer pool management of dry bulk vessels and technical management. The company generates maximum revenue from Singapore.

Share on Social Networks: